Skip to content

B-Neocept

by Organon, Inc.

510(k) K812334

B-Neocept is a medical device (FDA Class II; FDA product code JHJ, Agglutination Method, Human Chorionic Gonadotropin) made by Organon, Inc., cleared under FDA 510(k) K812334 on 1 Sep 1981, active as of 11 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 11 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 11 Oct 2026.

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK812334 Date1 Sep 1981ClearedStatusActive

Official records

From the FDA record

Received by the FDA
18 Aug 1981
FDA decision
1 Sep 1981 (Substantially Equivalent)
FDA review time
14 days from receipt to decision

From the FDA 510(k) record K812334 (openFDA), as read on 11 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
JHJ
Device class
Class II
Regulation
21 CFR Part 862.1155
Advisory committee
Clinical Chemistry
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code JHJ (Agglutination Method, Human Chorionic Gonadotropin).

Other devices from Organon, Inc.

See all devices from Organon, Inc. →